Sleep Apnea Diagnostic System Market to Soar in the Near Future Owing to Growing Consumer Adoption

The primary reasons driving the market's growth include the high incidence of obstructive sleep apnea, higher cases of comorbidities linked with sleep apnea, and a growing geriatric population prone to respiratory ailments. Furthermore, the rising prevalence of comorbidities associated with sleep apnea is boosting the use of diagnostic instruments. Obstructive Sleep Apnea (OSA) has also imposed an economic burden on society due to the presence of a significant number of undiagnosed patients, resulting in high collateral losses and public and private expenditure on management. For example, the overall economic impact of undiagnosed sleep apnea is estimated to be nearly USD 150 billion. As a result of a rising number of persons suffering from this illness, there is a greater demand for sleep apnea diagnostic instruments.

The global sleep apnea diagnostic system market is estimated to account for US$ 14,639.7 Mn in terms of value by the end of 2027.

Sleep apnea is a dangerous condition in which a person's breathing is interrupted while sleeping. Untreated sleep apnea causes people to stop breathing periodically during their sleep, which can happen anywhere from 5 to more than 50 times per hour. This means that the brain and the rest of the body may not receive adequate oxygen. Sleep apnea can cause a slew of health issues, including high blood pressure, stroke, heart failure, diabetes, depression, ADHD worsening, and headaches.

One in every five persons has moderate obstructive sleep apnea (OSA2), and 75 percent of severe sleep problem breathing cases remain diagnosed.

At the moment, the worldwide sleep diagnostic market is being pushed by an ageing population, technological advancements in the healthcare sector around the world, a growing rate of obesity in the population, and an increase in the incidence of sleep apnea.

Sleep apnea diagnostic global market drives by the increase in the obesity in population, increasing awareness regarding hypertension, strokes, and cardiovascular diseases and its association with sleep apnea, technological advancement in diagnostic devices. However, limited reimbursement, coupled with lack compliance are the major barrier for this market.